{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:37:32Z","timestamp":1791250652210,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s10549-014-3065-9","type":"journal-article","created":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T22:37:10Z","timestamp":1406932630000},"page":"119-132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Development and validation of a new algorithm for the reclassification of genetic variants identified in the BRCA1 and BRCA2 genes"],"prefix":"10.1007","volume":"147","author":[{"given":"Dmitry","family":"Pruss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisha","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Eggington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Esterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon S.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aric","family":"van Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla H.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin B.","family":"Roa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Gutin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Wenstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla R.","family":"Bowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,2]]},"reference":[{"issue":"11","key":"3065_CR1","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z","volume":"77","author":"EB Claus","year":"1996","unstructured":"Claus EB, Schildkraut JM, Thompson WD, Risch NJ (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77(11):2318\u20132324. doi: 10.1002\/(SICI)1097-0142(19960601)77:11<2318:AID-CNCR21>3.0.CO;2-Z","journal-title":"Cancer"},{"issue":"2","key":"3065_CR2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1098-2272(200002)18:2<173::AID-GEPI6>3.0.CO;2-R","volume":"18","author":"AC Antoniou","year":"2000","unstructured":"Antoniou AC, Gayther SA, Stratton JF, Ponder BA, Easton DF (2000) Risk models for familial ovarian and breast cancer. Genet Epidemiol 18(2):173\u2013190. doi: 10.1002\/(SICI)1098-2272(200002)18:2<173:AID-GEPI6>3.0.CO;2-R","journal-title":"Genet Epidemiol"},{"issue":"10","key":"3065_CR3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1054\/bjoc.2000.1407","volume":"83","author":"Anglian Breast Cancer Study Group","year":"2000","unstructured":"Anglian Breast Cancer Study Group (2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group. Br J Cancer 83(10):1301\u20131308. doi: 10.1054\/bjoc.2000.1407","journal-title":"Br J Cancer"},{"issue":"1","key":"3065_CR4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/GCO.0b013e328332dca3","volume":"22","author":"AW Kurian","year":"2010","unstructured":"Kurian AW (2010) BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications. Curr Opin Obstet Gynecol 22(1):72\u201378. doi: 10.1097\/GCO.0b013e328332dca3","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"4","key":"3065_CR5","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/GIM.0b013e31816b5cae","volume":"10","author":"CS Richards","year":"2008","unstructured":"Richards CS, Bale S, Bellissimo DB, Das S, Grody WW, Hegde MR, Lyon E, Ward BE, Molecular Subcommittee of the ALQAC (2008) ACMG recommendations for standards for interpretation and reporting of sequence variations: revisions 2007. Genet Med 10(4):294\u2013300. doi: 10.1097\/GIM.0b013e31816b5cae","journal-title":"Genet Med"},{"key":"3065_CR6","unstructured":"National Comprehensive Cancer Network (2014) Genetic\/familial high-risk assessment: breast and ovarian. NCCN Clin Pract Guidel Oncol (1.2014)"},{"issue":"4","key":"3065_CR7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248\u2013249. doi: 10.1038\/nmeth0410-248","journal-title":"Nat Methods"},{"issue":"5","key":"3065_CR8","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1101\/gr.176601","volume":"11","author":"PC Ng","year":"2001","unstructured":"Ng PC, Henikoff S (2001) Predicting deleterious amino acid substitutions. Genome Res 11(5):863\u2013874. doi: 10.1101\/gr.176601","journal-title":"Genome Res"},{"issue":"6","key":"3065_CR9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/hmg\/10.6.591","volume":"10","author":"S Sunyaev","year":"2001","unstructured":"Sunyaev S, Ramensky V, Koch I, Lathe W 3rd, Kondrashov AS, Bork P (2001) Prediction of deleterious human alleles. Hum Mol Genet 10(6):591\u2013597","journal-title":"Hum Mol Genet"},{"issue":"5","key":"3065_CR10","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1086\/521032","volume":"81","author":"DF Easton","year":"2007","unstructured":"Easton DF, Deffenbaugh AM, Pruss D, Frye C, Wenstrup RJ, Allen-Brady K, Tavtigian SV, Monteiro AN, Iversen ES, Couch FJ, Goldgar DE (2007) A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am J Hum Genet 81(5):873\u2013883. doi: 10.1086\/521032","journal-title":"Am J Hum Genet"},{"issue":"7","key":"3065_CR11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jmg.2003.015867","volume":"41","author":"V Abkevich","year":"2004","unstructured":"Abkevich V, Zharkikh A, Deffenbaugh AM, Frank D, Chen Y, Shattuck D, Skolnick MH, Gutin A, Tavtigian SV (2004) Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation. J Med Genet 41(7):492\u2013507","journal-title":"J Med Genet"},{"issue":"8899","key":"3065_CR12","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","volume":"343","author":"D Ford","year":"1994","unstructured":"Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE (1994) Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343(8899):692\u2013695","journal-title":"Lancet"},{"issue":"3","key":"3065_CR13","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62(3):676\u2013689","journal-title":"Am J Hum Genet"},{"issue":"7","key":"3065_CR14","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1200\/JCO.1998.16.7.2417","volume":"16","author":"TS Frank","year":"1998","unstructured":"Frank TS, Manley SA, Olopade OI, Cummings S, Garber JE, Bernhardt B, Antman K, Russo D, Wood ME, Mullineau L, Isaacs C, Peshkin B, Buys S, Venne V, Rowley PT, Loader S, Offit K, Robson M, Hampel H, Brener D, Winer EP, Clark S, Weber B, Strong LC, Thomas A et al (1998) Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol 16(7):2417\u20132425","journal-title":"J Clin Oncol"},{"issue":"9099","key":"3065_CR15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(97)07065-7","volume":"351","author":"LC Verhoog","year":"1998","unstructured":"Verhoog LC, Brekelmans CT, Seynaeve C, van den Bosch LM, Dahmen G, van Geel AN, Tilanus-Linthorst MM, Bartels CC, Wagner A, van den Ouweland A, Devilee P, Meijers-Heijboer EJ, Klijn JG (1998) Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 351(9099):316\u2013321","journal-title":"Lancet"},{"issue":"15","key":"3065_CR16","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","volume":"91","author":"Breast Cancer Linkage Consortium","year":"1999","unstructured":"Breast Cancer Linkage Consortium (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91(15):1310\u20131316","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"3065_CR17","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1158\/0008-5472.CAN-03-3823","volume":"64","author":"AP Klein","year":"2004","unstructured":"Klein AP, Brune KA, Petersen GM, Goggins M, Tersmette AC, Offerhaus GJ, Griffin C, Cameron JL, Yeo CJ, Kern S, Hruban RH (2004) Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 64(7):2634\u20132638","journal-title":"Cancer Res"},{"issue":"9","key":"3065_CR18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/jmg.2004.028829","volume":"42","author":"CJ Asperen van","year":"2005","unstructured":"van Asperen CJ, Brohet RM, Meijers-Heijboer EJ, Hoogerbrugge N, Verhoef S, Vasen HF, Ausems MG, Menko FH, Gomez Garcia EB, Klijn JG, Hogervorst FB, van Houwelingen JC, van\u2019t Veer LJ, Rookus MA, van Leeuwen FE, Netherlands Collaborative Group on Hereditary Breast C (2005) Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet 42(9):711\u2013719. doi: 10.1136\/jmg.2004.028829","journal-title":"J Med Genet"},{"issue":"11","key":"3065_CR19","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1200\/JCO.1999.17.11.3396","volume":"17","author":"LC Verhoog","year":"1999","unstructured":"Verhoog LC, Brekelmans CT, Seynaeve C, Dahmen G, van Geel AN, Bartels CC, Tilanus-Linthorst MM, Wagner A, Devilee P, Halley DJ, van den Ouweland AM, Meijers-Heijboer EJ, Klijn JG (1999) Survival in hereditary breast cancer associated with germline mutations of BRCA2. J Clin Oncol 17(11):3396\u20133402","journal-title":"J Clin Oncol"},{"key":"3065_CR20","doi-asserted-by":"crossref","unstructured":"Eggington JM, Bowles KR, Moyes K, Manley S, Esterling L, Sizemore S, Rosenthal E, Theisen A, Saam J, Arnell C, Pruss D, Bennett J, Burbidge LA, Roa B, Wenstrup RJ (2013) A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes. Clin Genet. doi: 10.1111\/cge.12315","DOI":"10.1111\/cge.12315"},{"issue":"9","key":"3065_CR21","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1182\/blood-2010-12-324541","volume":"118","author":"K Biswas","year":"2011","unstructured":"Biswas K, Das R, Alter BP, Kuznetsov SG, Stauffer S, North SL, Burkett S, Brody LC, Meyer S, Byrd RA, Sharan SK (2011) A comprehensive functional characterization of BRCA2 variants associated with Fanconi anemia using mouse ES cell-based assay. Blood 118(9):2430\u20132442. doi: 10.1182\/blood-2010-12-324541","journal-title":"Blood"},{"issue":"10","key":"3065_CR22","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/nm.2459","volume":"17","author":"S Chang","year":"2011","unstructured":"Chang S, Wang RH, Akagi K, Kim KA, Martin BK, Cavallone L, Kathleen Cuningham Foundation Consortium for Research into Familial Breast C, Haines DC, Basik M, Mai P, Poggi E, Isaacs C, Looi LM, Mun KS, Greene MH, Byers SW, Teo SH, Deng CX, Sharan SK (2011) Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155. Nat Med 17(10):1275\u20131282. doi: 10.1038\/nm.2459","journal-title":"Nat Med"},{"issue":"6","key":"3065_CR23","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1186\/bcr1826","volume":"9","author":"PK Lovelock","year":"2007","unstructured":"Lovelock PK, Spurdle AB, Mok MT, Farrugia DJ, Lakhani SR, Healey S, Arnold S, Buchanan D, kConFab I, Couch FJ, Henderson BR, Goldgar DE, Tavtigian SV, Chenevix-Trench G, Brown MA (2007) Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants? Breast Cancer Res 9(6):R82. doi: 10.1186\/bcr1826","journal-title":"Breast Cancer Res"},{"issue":"6","key":"3065_CR24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nsmb776","volume":"11","author":"RS Williams","year":"2004","unstructured":"Williams RS, Lee MS, Hau DD, Glover JN (2004) Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1. Nat Struct Mol Biol 11(6):519\u2013525. doi: 10.1038\/nsmb776","journal-title":"Nat Struct Mol Biol"},{"issue":"3","key":"3065_CR25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ng1196-253","volume":"14","author":"S Mazoyer","year":"1996","unstructured":"Mazoyer S, Dunning AM, Serova O, Dearden J, Puget N, Healey CS, Gayther SA, Mangion J, Stratton MR, Lynch HT, Goldgar DE, Ponder BA, Lenoir GM (1996) A polymorphic stop codon in BRCA2. Nat Genet 14(3):253\u2013254. doi: 10.1038\/ng1196-253","journal-title":"Nat Genet"},{"issue":"4","key":"3065_CR26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng1294-399","volume":"8","author":"LS Friedman","year":"1994","unstructured":"Friedman LS, Ostermeyer EA, Szabo CI, Dowd P, Lynch ED, Rowell SE, King MC (1994) Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 8(4):399\u2013404. doi: 10.1038\/ng1294-399","journal-title":"Nat Genet"},{"issue":"5182","key":"3065_CR27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266(5182):66\u201371","journal-title":"Science"},{"issue":"12","key":"3065_CR28","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1158\/0008-5472.CAN-09-4563","volume":"70","author":"MS Lee","year":"2010","unstructured":"Lee MS, Green R, Marsillac SM, Coquelle N, Williams RS, Yeung T, Foo D, Hau DD, Hui B, Monteiro AN, Glover JN (2010) Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays. Cancer Res 70(12):4880\u20134890. doi: 10.1158\/0008-5472.CAN-09-4563","journal-title":"Cancer Res"},{"issue":"4","key":"3065_CR29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1086\/424388","volume":"75","author":"DE Goldgar","year":"2004","unstructured":"Goldgar DE, Easton DF, Deffenbaugh AM, Monteiro AN, Tavtigian SV, Couch FJ, Breast Cancer Information Core Steering C (2004) Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. Am J Hum Genet 75(4):535\u2013544. doi: 10.1086\/424388","journal-title":"Am J Hum Genet"},{"issue":"9","key":"3065_CR30","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1158\/0008-5472.CAN-07-1587","volume":"68","author":"DJ Farrugia","year":"2008","unstructured":"Farrugia DJ, Agarwal MK, Pankratz VS, Deffenbaugh AM, Pruss D, Frye C, Wadum L, Johnson K, Mentlick J, Tavtigian SV, Goldgar DE, Couch FJ (2008) Functional assays for classification of BRCA2 variants of uncertain significance. Cancer Res 68(9):3523\u20133531. doi: 10.1158\/0008-5472.CAN-07-1587","journal-title":"Cancer Res"},{"key":"3065_CR31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4137\/CIN.S618","volume":"6","author":"R Karchin","year":"2008","unstructured":"Karchin R, Agarwal M, Sali A, Couch F, Beattie MS (2008) Classifying variants of undetermined significance in BRCA2 with protein likelihood ratios. Cancer Inform 6:203\u2013216","journal-title":"Cancer Inform"},{"key":"3065_CR32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/1471-2407-9-211","volume":"9","author":"L Mohammadi","year":"2009","unstructured":"Mohammadi L, Vreeswijk MP, Oldenburg R, van den Ouweland A, Oosterwijk JC, van der Hout AH, Hoogerbrugge N, Ligtenberg M, Ausems MG, van der Luijt RB, Dommering CJ, Gille JJ, Verhoef S, Hogervorst FB, van Os TA, Gomez Garcia E, Blok MJ, Wijnen JT, Helmer Q, Devilee P, van Asperen CJ, van Houwelingen HC (2009) A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example. BMC Cancer 9:211. doi: 10.1186\/1471-2407-9-211","journal-title":"BMC Cancer"},{"issue":"6","key":"3065_CR33","first-page":"1638","volume":"7","author":"E Ricevuto","year":"2001","unstructured":"Ricevuto E, Sobol H, Stoppa-Lyonnet D, Gulino A, Marchetti P, Ficorella C, Martinotti S, Meo T, Tosi M (2001) Diagnostic strategy for analytical scanning of BRCA1 gene by fluorescence-assisted mismatch analysis using large, bifluorescently labeled amplicons. Clin Cancer Res 7(6):1638\u20131646","journal-title":"Clin Cancer Res"},{"issue":"8","key":"3065_CR34","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/jmedgenet-2012-101037","volume":"49","author":"AB Spurdle","year":"2012","unstructured":"Spurdle AB, Whiley PJ, Thompson B, Feng B, Healey S, Brown MA, Pettigrew C, Van Asperen CJ, Ausems MG, Kattentidt-Mouravieva AA, van den Ouweland AM, Lindblom A, Pigg MH, Schmutzler RK, Engel C, Meindl A, Caputo S, Sinilnikova OM, Lidereau R, Couch FJ, Guidugli L, Hansen T, Thomassen M, Eccles DM, Tucker K, Benitez J, Domchek SM, Toland AE, Van Rensburg EJ, Wappenschmidt B, Borg A, Vreeswijk MP, Goldgar DE (2012) BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk. J Med Genet 49(8):525\u2013532. doi: 10.1136\/jmedgenet-2012-101037","journal-title":"J Med Genet"},{"issue":"1","key":"3065_CR35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.21629","volume":"33","author":"MP Vallee","year":"2012","unstructured":"Vallee MP, Francy TC, Judkins MK, Babikyan D, Lesueur F, Gammon A, Goldgar DE, Couch FJ, Tavtigian SV (2012) Classification of missense substitutions in the BRCA genes: a database dedicated to Ex-UVs. Hum Mutat 33(1):22\u201328. doi: 10.1002\/humu.21629","journal-title":"Hum Mutat"},{"issue":"1","key":"3065_CR36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1158\/0008-5472.CAN-12-2081","volume":"73","author":"L Guidugli","year":"2013","unstructured":"Guidugli L, Pankratz VS, Singh N, Thompson J, Erding CA, Engel C, Schmutzler R, Domchek S, Nathanson K, Radice P, Singer C, Tonin PN, Lindor NM, Goldgar DE, Couch FJ (2013) A classification model for BRCA2 DNA binding domain missense variants based on homology-directed repair activity. Cancer Res 73(1):265\u2013275. doi: 10.1158\/0008-5472.can-12-2081","journal-title":"Cancer Res"},{"issue":"9","key":"3065_CR37","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1074\/jbc.274.9.5659","volume":"274","author":"JE Meza","year":"1999","unstructured":"Meza JE, Brzovic PS, King MC, Klevit RE (1999) Mapping the functional domains of BRCA1. Interaction of the ring finger domains of BRCA1 and BARD1. J Biol Chem 274(9):5659\u20135665","journal-title":"J Biol Chem"},{"issue":"4","key":"3065_CR38","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ng1294-387","volume":"8","author":"LH Castilla","year":"1994","unstructured":"Castilla LH, Couch FJ, Erdos MR, Hoskins KF, Calzone K, Garber JE, Boyd J, Lubin MB, Deshano ML, Brody LC et al (1994) Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat Genet 8(4):387\u2013391. doi: 10.1038\/ng1294-387","journal-title":"Nat Genet"},{"issue":"4","key":"3065_CR39","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/ng1296-430","volume":"14","author":"LC Wu","year":"1996","unstructured":"Wu LC, Wang ZW, Tsan JT, Spillman MA, Phung A, Xu XL, Yang MC, Hwang LY, Bowcock AM, Baer R (1996) Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet 14(4):430\u2013440. doi: 10.1038\/ng1296-430","journal-title":"Nat Genet"},{"issue":"6","key":"3065_CR40","first-page":"1284","volume":"57","author":"LS Friedman","year":"1995","unstructured":"Friedman LS, Szabo CI, Ostermeyer EA, Dowd P, Butler L, Park T, Lee MK, Goode EL, Rowell SE, King MC (1995) Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J Hum Genet 57(6):1284\u20131297","journal-title":"Am J Hum Genet"},{"issue":"1\u20132","key":"3065_CR41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s004399900085","volume":"105","author":"RC Panguluri","year":"1999","unstructured":"Panguluri RC, Brody LC, Modali R, Utley K, Adams-Campbell L, Day AA, Whitfield-Broome C, Dunston GM (1999) BRCA1 mutations in African Americans. Hum Genet 105(1\u20132):28\u201331","journal-title":"Hum Genet"},{"issue":"12","key":"3065_CR42","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/bjc.1997.318","volume":"75","author":"IG Campbell","year":"1997","unstructured":"Campbell IG, Schroff R, Englefield P, Eccles DM (1997) BRCA1 polymorphisms. Br J Cancer 75(12):1854\u20131855","journal-title":"Br J Cancer"},{"key":"3065_CR43","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-2407-8-140","volume":"8","author":"E Machackova","year":"2008","unstructured":"Machackova E, Foretova L, Lukesova M, Vasickova P, Navratilova M, Coene I, Pavlu H, Kosinova V, Kuklova J, Claes K (2008) Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and\/or ovarian cancer. BMC Cancer 8:140. doi: 10.1186\/1471-2407-8-140","journal-title":"BMC Cancer"},{"issue":"6593","key":"3065_CR44","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/382678a0","volume":"382","author":"MS Chapman","year":"1996","unstructured":"Chapman MS, Verma IM (1996) Transcriptional activation by BRCA1. Nature 382(6593):678\u2013679. doi: 10.1038\/382678a0","journal-title":"Nature"},{"issue":"1","key":"3065_CR45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/jmg.2005.033258","volume":"43","author":"PK Lovelock","year":"2006","unstructured":"Lovelock PK, Healey S, Au W, Sum EY, Tesoriero A, Wong EM, Hinson S, Brinkworth R, Bekessy A, Diez O, Izatt L, Solomon E, Jenkins M, Renard H, Hopper J, Waring P, Tavtigian SV, Goldgar D, Lindeman GJ, Visvader JE, Couch FJ, Henderson BR, Southey M, Chenevix-Trench G, Spurdle AB, Brown MA (2006) Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants. J Med Genet 43(1):74\u201383. doi: 10.1136\/jmg.2005.033258","journal-title":"J Med Genet"},{"issue":"2","key":"3065_CR46","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0165-4608(01)00433-2","volume":"127","author":"K Laskie Ostrow","year":"2001","unstructured":"Laskie Ostrow K, DiCioccio RA, McGuire V, Whittemore AS (2001) A BRCA1 variant, IVS23+1G\u2192A, causes abnormal RNA splicing by deleting exon 23. Cancer Genet Cytogenet 127(2):188\u2013190","journal-title":"Cancer Genet Cytogenet"},{"issue":"11","key":"3065_CR47","first-page":"4259","volume":"6","author":"HA Shih","year":"2000","unstructured":"Shih HA, Nathanson KL, Seal S, Collins N, Stratton MR, Rebbeck TR, Weber BL (2000) BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers. Clin Cancer Res 6(11):4259\u20134264","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3065_CR48","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/81691","volume":"26","author":"CS Healey","year":"2000","unstructured":"Healey CS, Dunning AM, Teare MD, Chase D, Parker L, Burn J, Chang-Claude J, Mannermaa A, Kataja V, Huntsman DG, Pharoah PD, Luben RN, Easton DF, Ponder BA (2000) A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nat Genet 26(3):362\u2013364. doi: 10.1038\/81691","journal-title":"Nat Genet"},{"issue":"5","key":"3065_CR49","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/humu.20319","volume":"27","author":"X Chen","year":"2006","unstructured":"Chen X, Truong TT, Weaver J, Bove BA, Cattie K, Armstrong BA, Daly MB, Godwin AK (2006) Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression. Hum Mutat 27(5):427\u2013435. doi: 10.1002\/humu.20319","journal-title":"Hum Mutat"},{"issue":"18","key":"3065_CR50","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1093\/hmg\/dds222","volume":"21","author":"K Biswas","year":"2012","unstructured":"Biswas K, Das R, Eggington JM, Qiao H, North SL, Stauffer S, Burkett SS, Martin BK, Southon E, Sizemore SC, Pruss D, Bowles KR, Roa BB, Hunter N, Tessarollo L, Wenstrup RJ, Byrd RA, Sharan SK (2012) Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay. Hum Mol Genet 21(18):3993\u20134006. doi: 10.1093\/hmg\/dds222","journal-title":"Hum Mol Genet"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-3065-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-014-3065-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-3065-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T13:30:38Z","timestamp":1565703038000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-014-3065-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["3065"],"URL":"https:\/\/doi.org\/10.1007\/s10549-014-3065-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}